Zobrazeno 1 - 10
of 149
pro vyhledávání: '"Poulakaki, N."'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Background: Chemokines, cytokines in the immune microenvironment of tumors, may be associated with patient outcome. We assessed the impact of CXCL13 and CXCL9 on disease-free (DFS) and overall survival (OS), in an attempt to retrospectively evaluate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::42fbdf14691b7da24715ed04bddddd8f
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3077827
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3077827
Ki-67 is a marker of proliferating cells; this meta-analysis of cohort studies highlights that higher Ki-67 expression predicts recurrence rates in breast ductal carcinoma in situ. The predictive role of Ki-67 expression seems independent of cut-off
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::23ce713d7c6db814d3c091ca668ad8d5
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3086578
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3086578
Autor:
Strati A; Department of Chemistry, Analysis of Circulating Tumor Cells Laboratory, University of Athens, Greece., Zavridou M; Department of Chemistry, Analysis of Circulating Tumor Cells Laboratory, University of Athens, Greece., Kallergi G; Laboratory of Τumor Cell Biology, School of Medicine, University of Crete, Heraklion, Crete, Greece.; Division of Genetics, Cell, and Developmental Biology, Department of Biology, University of Patras, Patras, Greece., Politaki E; Laboratory of Τumor Cell Biology, School of Medicine, University of Crete, Heraklion, Crete, Greece., Kuske A; Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Gorges TM; Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Riethdorf S; Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Joosse SA; Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Koch C; Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Bohnen AL; Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Mueller V; Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Koutsodontis G; Oncology Unit, Second Department of Internal Medicine, Attikon University Hospital, Haidari, Greece., Kontopodis E; Department of Medical Oncology, University General Hospital of Heraklion, Crete, Greece., Poulakaki N; Breast Surgery Department, Euroclinic, Athens, Greece., Psyrri A; Oncology Unit, Second Department of Internal Medicine, Attikon University Hospital, Haidari, Greece., Mavroudis D; Laboratory of Τumor Cell Biology, School of Medicine, University of Crete, Heraklion, Crete, Greece.; Department of Medical Oncology, University General Hospital of Heraklion, Crete, Greece., Georgoulias V; Laboratory of Τumor Cell Biology, School of Medicine, University of Crete, Heraklion, Crete, Greece., Pantel K; Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Lianidou ES; Department of Chemistry, Analysis of Circulating Tumor Cells Laboratory, University of Athens, Greece.
Publikováno v:
Clinical chemistry [Clin Chem] 2021 Oct 01; Vol. 67 (10), pp. 1395-1405.
BACKGROUND Hidradenitis suppurativa (HS) is a chronic inflammatory disease that frequently involves the perineal and perianal regions. The association between HS and malignant transformation is a rare but under recognized phenomenon. OBJECTIVE This s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::b51bfe52c6f770216db7b1f0a9f22235
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3126613
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3126613
Purpose: Local recurrence is considered a major concern in patients diagnosed with ductal carcinoma in situ (DCIS), as its invasive occurrence is associated with high rates of distant disease and mortality. This study aims to assess the possible corr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::7aea41ff5e920ddb872d14f2d0909e79
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3086242
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3086242
Autor:
Razis E; Third Department of Medical Oncology, Hygeia Hospital, Athens, Greece. Electronic address: e.razis@hygeia.gr., Kalogeras KT; Translational Research Section, Hellenic Cooperative Oncology Group, Athens, Greece; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, Thessaloniki, Greece., Kotsantis I; Section of Medical Oncology, Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece., Koliou GA; Section of Biostatistics, Hellenic Cooperative Oncology Group, Data Office, Athens, Greece., Manousou K; Section of Biostatistics, Hellenic Cooperative Oncology Group, Data Office, Athens, Greece., Wirtz R; STRATIFYER Molecular Pathology GmbH, Cologne, Germany., Veltrup E; STRATIFYER Molecular Pathology GmbH, Cologne, Germany., Patsea H; Department of Pathology, IASSO General Hospital, Athens, Greece., Poulakaki N; Breast Surgery Clinic, Euroclinic, Athens, Greece., Dionysopoulos D; Department of Medical Oncology, Papageorgiou Hospital, Aristotle University of Thessaloniki, School of Health Sciences, Faculty of Medicine, Thessaloniki, Greece., Pervana S; Department of Pathology, Papageorgiou Hospital, Thessaloniki, Greece., Gogas H; First Department of Medicine, Laiko General Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece., Koutras A; Division of Oncology, Department of Medicine, University Hospital, University of Patras Medical School, Patras, Greece., Pentheroudakis G; Department of Medical Oncology, Ioannina University Hospital, Ioannina, Greece., Christodoulou C; Second Department of Medical Oncology, Metropolitan Hospital, Piraeus, Greece., Linardou H; Oncology Unit, Metropolitan Hospital, Piraeus, Greece., Pavlakis K; Pathology Department, National and Kapodistrian University of Athens School of Medicine, Athens, Greece., Koletsa T; Department of Pathology, Aristotle University of Thessaloniki, School of Health Sciences, Faculty of Medicine, Thessaloniki, Greece., Pectasides D; Oncology Section, Second Department of Internal Medicine, Hippokration Hospital, Athens, Greece., Zagouri F; Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece., Fountzilas G; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, Thessaloniki, Greece; Aristotle University of Thessaloniki, Thessaloniki, Greece.
Publikováno v:
Clinical breast cancer [Clin Breast Cancer] 2020 Feb; Vol. 20 (1), pp. e36-e53. Date of Electronic Publication: 2019 Sep 05.
Background: The host's immune system is crucially involved in cancer development and progression. The ratio of regulatory to effector T-cells, as well as the interplay of T-cells with therapeutic agents, impact on cancer prognosis. The current study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::48c868555de737651617d18b6eba68e5
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3088357
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3088357
Purpose of investigation: The aim of the present study was to record how the treatment of female cancer may affect sexuality and interpersonal relations in the couple. Material and Methods: From September 2008 until February 2012, the authors prospec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::c58f5b05fb842769c98108634ec0dcc6
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3127056
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3127056
Aims and background: The understanding of hormonal therapies in postmenopausal women with metastatic breast cancer has advanced greatly in the past several decades. With the introduction of orally active, potent and selective third-generation aromata
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::0fe61e86a8067d807268437d5c9567d3
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3094920
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3094920